ABSTRACT
Background@#Human blood groups may play a key role in various human diseases. An association has been found between ABO blood groups and both infectious and non-infectious diseases of the gastrointestinal tract and other organs. Dyspepsia is one of the most common encountered gastrointestinal complaints. @*Aims@#To investigate the association between ABO blood groups and severity of dyspepsia symptoms in a specific ethnic group. @*Study Design@#Cross-sectional study. @*Methods@#Consecutive adult Nias tribe dyspepsia outpatients in the General District Hospital, Gunungsitoli Nias,Indonesia, were interviewed using a structured questionnaire between May–June 2018. The severity of dyspepsia was assessed with the Porto Alegre Dyspeptic Symptoms Questionnaire (PADYQ) scoring instrument. ABO blood groups were determined by a standard direct agglutination test. Upper gastrointestinal endoscopy was performed in all participants. Data were statistically analyzed using statistical software. P value less than 0.05 was considered as statistically significant. @*Results@#Of 66 patients, 54.5% were males, with median age of 47 years (range, 23–67). Majority of the participants had blood group O (48.5%). The most encountered dyspepsia symptom was epigastric pain (66.7%). Participants with blood group type B had significantly more severe dyspepsia symptoms based on total PADYQ score (p=0.017). Participants with blood group type O were more prone to epigastric pain (p=0.015), while blood group type B to bloating (p=0.01) and early satiation (p=0.02). @*Conclusion@#In outpatients from the Nias tribe with dyspepsia, those with blood group type B had more severe dyspepsia symptoms.
Subject(s)
ABO Blood-Group SystemABSTRACT
Objective To explore the efficacy and safety of compound azintamide enteric‐coated tablets in the treatment of patients with dyspepsia after gastrointestinal surgery .Methods Multicenter , randomized ,double blind ,placebo‐controlled ,parallel controlled method w as applied .From January 2011 to January 2013 , of 240 patients with dyspepsia after gastrointestinal surgery from 12 hospitals in Shanghai were enrolled and divided into medicine treatment group (n= 120) and placebo control group (n= 120 ) ,received compound azintamide enteric‐coated tablets or placebo , respectively . Compound azintamide enteric‐coated tablet (100 mg) or placebo was oral taken each time ,three times per day for four weeks .Total and respective score of dyspeptic symptoms (abdominal distension ,loss of appetite ,early satiety ,belching ,nausea ,abdominal pain or abdominal discomfort) were evaluated prior to study and on the 1st , 2nd , 3rd and 4th week after treatment . On the 4th week after treatment ,the efficacy of the improvement of dyspeptic symptoms was compared between the two groups ,and the safety was also evaluated .The score of the quality‐of‐life was compared between the two groups prior to study and on the 4thweek after treatment .The t‐test was performed for comparison between measurement data ,Chi‐square test was used for count data ,and rank sum test was used for rank data .Results At one week after treatment ,the scores of abdominal distension (4 .61 ± 0 .98 ) ,early satiety (2 .87 ± 0 .64 ) ,belching (3 .03 ± 0 .58) ,abdominal pain or abdominal discomfort (3 .13 ± 0 .79) and total score (18 .32 ± 3 .44) of patients in medicine treatment group were significantly lower than those of placebo control group (8 .83 ± 1 .28、4 .28 ± 0 .61、4 .87 ± 1 .07、5 .46 ± 0 .87、29 .63 ± 5 .50) ,and the differences were statistically significant (t=28 .524、17 .400、16 .453、21 .619 and 18 .983 ,all P 0 .05) .At 2nd ,3rd and 4th week after treatment ,respective score of dyspeptic symptoms and total score of medicine treatment group (2nd week:2.57±1.28,1.87±1.17,1.55±1.27,1.55±1.08,1.09±0.82,1.98±1.02,10.53±4.54,3rdweek:1 .42 ± 0 .60 ,1 .11 ± 0 .45 ,0 .94 ± 0 .37 ,0 .94 ± 0 .41 ,0 .79 ± 0 .31 ,1 .42 ± 0 .55 ,6 .52 ± 2 .41 ,4th w eek:1.13±0.51,0.46±0.12,0.58±0.13,0.38±0.16,0.30±0.07,0.81±0.33,3.65±1.06)wereall significantly lower than those of placebo control group (2nd week:8 .50 ± 2 .61 ,3 .78 ± 2 .01 ,4 .08 ± 2 .14 , 4.73±2.64,2.27±2.13,4.91±2.24,28.25±8.86,3rdweek:7.92±2.51,3.68±1.76,4.08±1.86, 4.71±1.77,2.14±0.83,5.01±1.31,27.54±8.09,4th week:7.63±2.37,3.67±1.63,3.92±2.08, 4 .66 ± 2 .95 ,2 .14 ± 1 .65 ,4 .67 ± 2 .34 ,and 26 .68 ± 7 .45) ,and the differences were statistically significant (all t=0 .000 ,all P<0 .01) .At 4th week after treatment ,the total efficacy of total score improvement of dyspepsia symptoms in medicine treatment group was 86 .21% (100/116) ,which was significantly better than that of placebo control group (39 .16% (47/120)) ,and the difference was statistically significant (Z=9 .464 ,P<0 .01) .The total score of quality of life in medicine treatment group was significantly lower than that of placebo control group (12 .24 ± 4 .30 and 22 .13 ± 6 .18) ,and the difference was statistically significant (t=14 .225 , P< 0 .01 ) .No adverse events was observed in both groups during treatment period . Conclusion Compound azintamide enteric‐coated tablets may effectively improve dyspeptic symptoms and quality of life in patients with dyspepsia after gastrointestinal surgery ,and with good safety .
ABSTRACT
This study investigated whether the curative effect of short-pulse gastric electrical stimulation (GES) on the vasopressin-induced dyspeptic symptoms was mediated by central opioid peptide-producing neurons. Five female beagle dogs implanted with 1 pair of electrodes in gastric serosa were used in a two-experiment study. In experiment one,the brain was scanned by positron emission tomography in 3 dogs with and without short-pulse GES,and the radioactivity in nuclei of solitary tract (NST) and hypothalamus was detected. Experiment two was composed of 4 sessions. In session one,the dogs were injected with vasopressin in the absence of short-pulse GES. With session two,the short-pulse GES was simultaneously given via the electrodes with the injection of vasopressin. In sessions three and four,naloxone and naloxone methiodide was administered respectively in the presence of short-pulse GES. Motion sickness-like symptoms were scored and compared among the different sessions. The results showed that the short-pulse GES significantly increased the radioactivity in NST and hypothalamic nuclei (P＜0.05,vs control). The short-pulse GES could ameliorate the vasopressin-induced motion sickness-like symptoms in dogs. Naloxone,but not naloxone methiodide could attenuate the curative effects of short-pulse GES. It is concluded that NST and hypothalamic nuclei may participate in the mediation of the curative effects of short-pulse GES on dyspepsia-like symptoms. Central opioid peptide-containing neurons presumably mediate the therapeutic effect on dyspeptic symptoms of short-pulse GES.
ABSTRACT
The aim of our study was to determine the effect of Cisapride on gastric emptying and dyspeptic symptoms in 10 non-ulcer dyspepsia (NUD) children with delayed gastric emptying during and after stopping treatment. Five boys and five girls aged 5-11 years underwent upper endoscopy which showed normal appearing mucosa and histology. Solid gastric emptying was measured by scintigraphy before and after an eight-week course of oral Cisapride. The dose of cisapride was 0.2 mg/kg/dose (maximum 5 mg) three times before meals for eight weeks and then gradually decreased and discontinued when the symptoms improved. Symptoms were show to be 87.4+3.4 percent and 82.9 (4.5 percent at 60 minutes and 90 minutes, respectively. After eight-weeks of treatment, repeated gastric emptying studies were shown to be 69.1+10.6 percent and 56.7+14.1 percent respectively. This was statistically significant (P=0.001, 0.0001). In all 10 children the symptoms improved after eight-weeks of treatment. Seven children were followed up after stopping cisapride for 3 to 17.5 months. The overall response were excellent in four patients, moderate in two Cisapride is effective in improving dyspeptic symptoms and gastric emptying in children with NUD.